Abel Joseph(@AbelJosephMD) 's Twitter Profileg
Abel Joseph

@AbelJosephMD

GI fellow @Stanford_GI 💩 | Medicine @ClevelandClinic | Research @Duke_GI_ #MedEd ❤️ Innovation. How we treat people ultimately tells all 🇺🇸🇮🇳

ID:304439569

linkhttps://scholar.google.com/citations?hl=en&authuser=1&user=qUE1gtkAAAAJ calendar_today24-05-2011 14:27:14

1,5K Tweets

2,6K Followers

666 Following

Amit Bhatt MD(@amitbhattMD) 's Twitter Profile Photo

ESD is better with traction 💪
Not only for efficiency but maybe oncologic outcomes as well. Our multi-center results of ESD with and without traction for T1b esophageal cancer.
Thanks Abel Joseph Kornpong 'KP' Vantanasiri Prasad G. Iyer, MD and all co-authors for their collaboration!

ESD is better with traction 💪 Not only for efficiency but maybe oncologic outcomes as well. Our multi-center results of ESD with and without traction for T1b esophageal cancer. Thanks @AbelJosephMD @kornpongv @PrasadIyerMD and all co-authors for their collaboration!
account_circle
GIE(@GIE_Journal) 's Twitter Profile Photo

Online now in GIE’s Articles in Press: “Endoscopic submucosal dissection with versus without traction for pathologically staged T1B esophageal cancer: a multicenter retrospective study” by Abel Joseph et al. giejournal.org/article/S0016-…

Amit Bhatt MD @abeljosephMD @prasadIyerMD

Online now in GIE’s Articles in Press: “Endoscopic submucosal dissection with versus without traction for pathologically staged T1B esophageal cancer: a multicenter retrospective study” by Abel Joseph et al. giejournal.org/article/S0016-… @amitbhattMD @abeljosephMD @prasadIyerMD
account_circle
Rashmi Advani, MD, ABOM-D(@AdvaniRashmiMD) 's Twitter Profile Photo

Our CrushingGIBoards family has grown! We are so proud of all of our board members and contributors over the last year who continue to deliver excellent high-yield content to our GI Twitter Family

🌟 If you wish to be a contributor, DM us!

Save & share!

Our @CrushingGIBoard family has grown! We are so proud of all of our board members and contributors over the last year who continue to deliver excellent high-yield #GIBoard content to our GI Twitter Family 🌟 If you wish to be a contributor, DM us! Save & share! #MedTwitter
account_circle
Mustafa Suleyman(@mustafasuleyman) 's Twitter Profile Photo

I’m excited to announce that today I’m joining Microsoft as CEO of Microsoft AI. I’ll be leading all consumer AI products and research, including Copilot, Bing and Edge. My friend and longtime collaborator Karén Simonyan will be Chief Scientist, and several of our amazing…

account_circle
Anmol Goyal(@AnmolGoyalMD) 's Twitter Profile Photo

So excited to become part of this amazing family for the next chapter in my training! Super grateful for all the support I've received along the way, can't wait to meet everyone in the summer! Cleveland Clinic IM Richard M. Wardrop III, MD, PhD, FAAP, FACP, SFHM

So excited to become part of this amazing family for the next chapter in my training! Super grateful for all the support I've received along the way, can't wait to meet everyone in the summer! @CCF_IMCHIEFS @Mud_Fud #Match2024
account_circle
Stanford Department of Medicine(@StanfordDeptMed) 's Twitter Profile Photo

Presenting 's 2024-2025 class of *extraordinary* interns! Join us in welcoming our 59 incoming interns, whose matches were made possible by the collective effort of our department members! StanfordMedRes

Presenting #StanDOM's 2024-2025 class of *extraordinary* interns! Join us in welcoming our 59 incoming interns, whose matches were made possible by the collective effort of our department members! #Match2024 #MatchDay @StanfordMedRes
account_circle
Darren Liu(@liu_darren9) 's Twitter Profile Photo

Thrilled to have matched in Internal Medicine/ Research Pathway in GI at Cleveland Clinic IM!! Immensely grateful for everyone's support 🥹. Forever thankful to Richard M. Wardrop III, MD, PhD, FAAP, FACP, SFHM Jean-Paul Achkar Michelle Kim Cleveland Clinic Lerner College of Medicine for supporting my aspirations of becoming a physician-scientist🙏

Thrilled to have matched in Internal Medicine/#ABIM Research Pathway in GI at @CCF_IMCHIEFS!! Immensely grateful for everyone's support 🥹. Forever thankful to @Mud_Fud @JPAchkarMD @MichelleKimMD @CleClinicLCM for supporting my aspirations of becoming a physician-scientist🙏
account_circle
Cleveland Clinic IM(@CCF_IMCHIEFS) 's Twitter Profile Photo

We want to extend a warm welcome to our CLASS OF 2027!! We’re so excited to welcome you to the CCF IMRP family and can’t wait to meet you all in person soon! Richard M. Wardrop III, MD, PhD, FAAP, FACP, SFHM NRMP®

We want to extend a warm welcome to our CLASS OF 2027!! We’re so excited to welcome you to the CCF IMRP family and can’t wait to meet you all in person soon! @Mud_Fud @TheNRMP
account_circle
American Gastroenterological Association (AGA)(@AmerGastroAssn) 's Twitter Profile Photo

Having data on a new blood-based screening test for is exciting. Blood tests are not interchangeable with colonoscopy for CRC screening but should prove to be an additional tool to help identify CRC early. Read our full statement: ow.ly/kxhY50QTfBP

account_circle
NEJM(@NEJM) 's Twitter Profile Photo

In adults undergoing screening colonoscopy, a next-generation multitarget stool DNA test had higher sensitivity for colorectal cancer and advanced precancerous lesions than a fecal immunochemical test but lower specificity. Full BLUE-C study results: nej.md/4abqpSZ

In adults undergoing screening colonoscopy, a next-generation multitarget stool DNA test had higher sensitivity for colorectal cancer and advanced precancerous lesions than a fecal immunochemical test but lower specificity. Full BLUE-C study results: nej.md/4abqpSZ
account_circle
NEJM(@NEJM) 's Twitter Profile Photo

In a cohort at average risk for colorectal cancer, a cell-free DNA blood-based test had 83% sensitivity for colorectal cancer, 90% specificity for advanced neoplasia, and 13% sensitivity for advanced precancerous lesions. Full ECLIPSE study results: nej.md/3v0J319

In a cohort at average risk for colorectal cancer, a cell-free DNA blood-based test had 83% sensitivity for colorectal cancer, 90% specificity for advanced neoplasia, and 13% sensitivity for advanced precancerous lesions. Full ECLIPSE study results: nej.md/3v0J319
account_circle